6-32444069-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019111.5(HLA-DRA):​c.*11+148C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.772 in 511,156 control chromosomes in the GnomAD database, including 153,196 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.77 ( 44948 hom., cov: 31)
Exomes 𝑓: 0.77 ( 108248 hom. )

Consequence

HLA-DRA
NM_019111.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.350

Publications

44 publications found
Variant links:
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.812 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HLA-DRANM_019111.5 linkc.*11+148C>G intron_variant Intron 4 of 4 ENST00000395388.7 NP_061984.2 P01903A0A0G2JMH6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-DRAENST00000395388.7 linkc.*11+148C>G intron_variant Intron 4 of 4 6 NM_019111.5 ENSP00000378786.2 P01903
HLA-DRAENST00000374982.5 linkc.*11+148C>G intron_variant Intron 4 of 4 6 ENSP00000364121.5 Q30118
ENSG00000299747ENST00000766007.1 linkn.163-5809G>C intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.768
AC:
116661
AN:
151994
Hom.:
44933
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.717
Gnomad AMI
AF:
0.895
Gnomad AMR
AF:
0.797
Gnomad ASJ
AF:
0.851
Gnomad EAS
AF:
0.833
Gnomad SAS
AF:
0.812
Gnomad FIN
AF:
0.723
Gnomad MID
AF:
0.791
Gnomad NFE
AF:
0.784
Gnomad OTH
AF:
0.797
GnomAD4 exome
AF:
0.773
AC:
277676
AN:
359044
Hom.:
108248
AF XY:
0.775
AC XY:
140847
AN XY:
181712
show subpopulations
African (AFR)
AF:
0.708
AC:
6464
AN:
9124
American (AMR)
AF:
0.791
AC:
7216
AN:
9118
Ashkenazi Jewish (ASJ)
AF:
0.836
AC:
8706
AN:
10418
East Asian (EAS)
AF:
0.815
AC:
19507
AN:
23938
South Asian (SAS)
AF:
0.826
AC:
8698
AN:
10524
European-Finnish (FIN)
AF:
0.725
AC:
17714
AN:
24448
Middle Eastern (MID)
AF:
0.807
AC:
1294
AN:
1604
European-Non Finnish (NFE)
AF:
0.771
AC:
191892
AN:
249018
Other (OTH)
AF:
0.776
AC:
16185
AN:
20852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2999
5999
8998
11998
14997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2150
4300
6450
8600
10750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.767
AC:
116728
AN:
152112
Hom.:
44948
Cov.:
31
AF XY:
0.766
AC XY:
56968
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.716
AC:
29724
AN:
41498
American (AMR)
AF:
0.796
AC:
12167
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.851
AC:
2951
AN:
3468
East Asian (EAS)
AF:
0.833
AC:
4308
AN:
5174
South Asian (SAS)
AF:
0.812
AC:
3906
AN:
4812
European-Finnish (FIN)
AF:
0.723
AC:
7634
AN:
10562
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.784
AC:
53303
AN:
67992
Other (OTH)
AF:
0.798
AC:
1688
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1356
2712
4068
5424
6780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
868
1736
2604
3472
4340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.783
Hom.:
22584
Bravo
AF:
0.773
Asia WGS
AF:
0.783
AC:
2725
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
5.9
DANN
Benign
0.63
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239802; hg19: chr6-32411846; API